Research and Clinical Trials
Research is being conducted in both the laboratories at the Icahn School of Medicine and in The Mount Sinai Hospital to uncover the causes of movement disorders and to develop new treatments. Ultimately, research discoveries will improve the quality of life for people living with movement disorders.
Basic Science Research
At the Friedman Brain Institute at Mount Sinai, scientists are uncovering important information about movement disorders, including clues to the underlying genetic mechanisms. With this new information, researchers are better able to develop new methods for diagnosing and treating movement disorders.
At the same time scientists in the laboratory are uncovering new knowledge about the biologic mechanisms underlying movement disorders, clinicians are collaborating with people living with movement disorders to evaluate and discover new treatment options. The Robert and John M. Bendheim Parkinson and Movement Disorders Center at Mount Sinai has an extensive clinical trials program, where patients are invited to participate in novel clinical research studies exploring the effectiveness of new treatments. Patients who participate in clinical trials have access to the latest experimental evaluations and therapies as well as ongoing clinical care.
Recent and ongoing research includes:
- Clinical research studies on experimental therapeutics for Parkinson’s disease, dystonia, essential tremor, and other movement disorders
- Studies on the genetic mechanisms underlying development of dystonia, Parkinson’s disease, and spasmodic dysphonia
- Research into the behavioral aspects of Parkinson’s disease, such as emotional processing deficits and impulse control disorders as well as the effects of deep brain stimulation (DBS) on Parkinson’s disease motor features and gait disorders
Robert and John M. Bendheim Parkinson and Movement Disorders Center
5 East 98th Street, Box 1138
New York, NY 10029-6574